Skip to content

Clinical trials

Phase 3 Carcinoma, Hepatocellular trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 3 Country / region: South Korea Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20063
20071
20084
20092
20106
20112
20135
20141
20153
20172
20185
20194
20201
20221
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Terminated7
Active, not recruiting6
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Bayer5
Bristol-Myers Squibb5
Merck Sharp & Dohme LLC4
Hoffmann-La Roche3
Eli Lilly and Company2
Exelixis2
Imunon2
Seoul National University Hospital2
Abbott1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular46
Liver Neoplasms14
Neoplasms7
Carcinoma4
Adenocarcinoma2
Digestive System Diseases2
Digestive System Neoplasms2
Liver Diseases2
Neoplasms by Histologic Type2
Neoplasms by Site2

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.